Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Device Inspection Survey Shows FDA Consistency, Image Improvement

This article was originally published in The Gray Sheet

Executive Summary

FDA inspections of medical device companies are consistent across different Office of Regulatory Affairs district offices, according to a survey organized by the Medical Device Industry Initiative Grassroots Taskforce.

You may also be interested in...



BIMO Routine Inspections Will Be Pre-Announced

CDRH's bioresearch monitoring division (BIMO) has started pre-announcing routine audits. Under the new policy, the inspections are being announced about five days beforehand

BIMO Routine Inspections Will Be Pre-Announced

CDRH's bioresearch monitoring division (BIMO) has started pre-announcing routine audits. Under the new policy, the inspections are being announced about five days beforehand

FDA'S PILOT INSPECTION PROGRAM TO BECOME PERMANENT, AGENCY'S CHESEMORE TELLS HIMA; EIRs WILL AUTOMATICALLY BE ISSUED TO MANUFACTURERS BEGINNING IN APRIL

FDA's pilot pre-announced inspection program for device manufacturers is being made permanent, Ronald Chesemore, the agency's associate commissioner for regulatory affairs, told attendees at the Health Industry Manufacturers Association annual meeting March 16 in St. Petersburg, Florida. Encouraged by favorable feedback from FDA inspectors and industry, the agency has decided to implement the initiative as a "permanent change in our medical device program," Chesemore said.

Related Content

UsernamePublicRestriction

Register

MT014801

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel